Return to Listing

4 result(s) for Gynecologic Cancers

PI Name Protocol # Title
Paul Spellman IRB00010163 Reconstructing the Tumor Genome in Peripheral Blood
Matthew Taylor IRB00010605 A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD5363 under Adaptable Dosing Schedules in Patients with Advanced Solid Malignancies
Matthew Taylor IRB00011804 A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors
Lara Davis IRB00012039 Sarcoma Survivorship Registry

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080